How Are The Mid-Sized Life Sciences Organizations Using Oracle Clinical Trial Technology To Optimize

How Are The Mid-Sized Life Sciences Organizations Using Oracle Clinical Trial Technology To Optimize Studies?

Source – Life Sciences Review

Optimizing clinical trials’ efficiency is crucial for research institutions to deliver the needed therapies faster.

FREMONT, CA: To attain the goal of research institutions seeking to deliver the needed therapies faster goal, full-service clinical research organization (CRO), Peachtree BioResearch Solutions has chosen Oracle Health Sciences cloud services to optimize its clinical startup management activities.

Peachtree BioResearch Solutions offers global development services for increasing to mid-sized biotechnology, pharmaceutical, and medical device companies. The company will utilize the Oracle Health Sciences Select Cloud Service, Activate Cloud Service, and Siebel Clinical Trial Management System to instantly plan, manage, set-up, monitor, and analyze the clinical trials for its mid-sized customers.

Peachtree is placing the Activate Express configuration, mainly designed to accelerate and streamline the implementation process for the mid-sized biotech companies and regional CROs in order to optimize site selection and activation activities, utilizing the most advanced and proven startup workflow engine available.

The president, CEO, and co-founder of Peachtree, Kristy Nichols, states that streamlining communication and offering transparency into startup activities with their stakeholders is critical to the process optimization efforts and the delivery speed of therapies to patients in need. Oracle Health Sciences solutions improve their clinical business intelligence and management capabilities, enabling them to make timely interventions and course corrections and uncover insights into the ripe processes for future enhancements, eventually leading to timeline reductions and better operational performance.

Study startup that consists of activities associated with the site identification, feasibility assessment, selection, activation, and monitoring is a notorious bottleneck in the clinical trials. Several factors can impact the study startup, comprising the contract and budget negotiations, regulatory changes, compliance, Institutional Review Board approvals, clinical staff turnover, and so on. All of these contribute to substantial trial delays and cost overages.

Oracle’s Select Cloud Service and Activate Cloud Service solutions will allow Peachtree to optimize the various study startup steps with workflow automation and real-time insights into the study status, making it easier to ensure quality team performance allows the discovery of meaningful patterns in study data.

Beyond simple aggregation of site information, Select Cloud Service provides a data-driven approach to identify sites and target populations ideally suited to studies. Activate Cloud Service streamlines the startup process of study-specific workflows and enhances real-time oversight for clinical operations management by tracking milestones on the critical path and providing transparent, user-friendly document management capabilities that support

regulatory compliance. These insights guide organizations in their optimization efforts and provide a stark contrast to the manual, time-consuming methods still predominantly used across the industry.